Meike Kespohl

646 total citations
16 papers, 470 citations indexed

About

Meike Kespohl is a scholar working on Immunology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Meike Kespohl has authored 16 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Cardiology and Cardiovascular Medicine and 6 papers in Molecular Biology. Recurrent topics in Meike Kespohl's work include Viral Infections and Immunology Research (10 papers), interferon and immune responses (8 papers) and Peptidase Inhibition and Analysis (4 papers). Meike Kespohl is often cited by papers focused on Viral Infections and Immunology Research (10 papers), interferon and immune responses (8 papers) and Peptidase Inhibition and Analysis (4 papers). Meike Kespohl collaborates with scholars based in Germany, United States and France. Meike Kespohl's co-authors include Antje Beling, Karin Klingel, Hani Harb, Harald Renz, Thomas Boettger, Philippe Schmitt‐Kopplin, Alexander Visekruna, Sabine Pautz, Svenja Wolff and Stefan Offermanns and has published in prestigious journals such as Circulation, Arteriosclerosis Thrombosis and Vascular Biology and Science Advances.

In The Last Decade

Meike Kespohl

14 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meike Kespohl Germany 9 281 171 118 88 62 16 470
Tai‐Ju Hwang South Korea 11 179 0.6× 128 0.7× 70 0.6× 34 0.4× 56 0.9× 25 489
Daniel Peltier United States 14 252 0.9× 232 1.4× 88 0.7× 10 0.1× 103 1.7× 32 590
Sadia Ahmad United Kingdom 9 179 0.6× 95 0.6× 22 0.2× 48 0.5× 54 0.9× 22 433
Honglin Xu China 12 109 0.4× 343 2.0× 83 0.7× 26 0.3× 28 0.5× 21 549
Andrew D. Hildreth United States 9 123 0.4× 281 1.6× 40 0.3× 30 0.3× 19 0.3× 10 472
Amanda Fisher United States 8 444 1.6× 304 1.8× 49 0.4× 31 0.4× 34 0.5× 9 585
Zaneta Sibinska Germany 5 167 0.6× 201 1.2× 32 0.3× 52 0.6× 11 0.2× 6 494
Fabian Linden Germany 11 157 0.6× 201 1.2× 28 0.2× 40 0.5× 98 1.6× 16 414
Elisabeth Errazuriz-Cerda France 9 140 0.5× 99 0.6× 43 0.4× 17 0.2× 158 2.5× 13 441

Countries citing papers authored by Meike Kespohl

Since Specialization
Citations

This map shows the geographic impact of Meike Kespohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meike Kespohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meike Kespohl more than expected).

Fields of papers citing papers by Meike Kespohl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meike Kespohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meike Kespohl. The network helps show where Meike Kespohl may publish in the future.

Co-authorship network of co-authors of Meike Kespohl

This figure shows the co-authorship network connecting the top 25 collaborators of Meike Kespohl. A scholar is included among the top collaborators of Meike Kespohl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meike Kespohl. Meike Kespohl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Kespohl, Meike, Kalimuthu Karuppanan, Philomena Mburu, et al.. (2025). Assessing customized multivalent chemokine-binding peptide treatment in a murine model of coxsackievirus B3 myocarditis. Basic Research in Cardiology. 120(2). 393–422.
3.
Kespohl, Meike, Carl Christoph Goetzke, Nadine Althof, et al.. (2024). TF-FVIIa PAR2-β-Arrestin Signaling Sustains Organ Dysfunction in Coxsackievirus B3 Infection of Mice. Arteriosclerosis Thrombosis and Vascular Biology. 44(4). 843–865. 1 indexed citations
4.
Voß, Martin, Sandra Pinkert, Meike Kespohl, et al.. (2022). A Conserved Cysteine Residue in Coxsackievirus B3 Protein 3A with Implication for Elevated Virulence. Viruses. 14(4). 769–769. 1 indexed citations
5.
Goetzke, Carl Christoph, Nadine Althof, Ziya Kaya, et al.. (2021). Mitigated viral myocarditis in A/J mice by the immunoproteasome inhibitor ONX 0914 depends on inhibition of systemic inflammatory responses in CoxsackievirusB3 infection. Basic Research in Cardiology. 116(1). 7–7. 10 indexed citations
6.
Pinkert, Sandra, Meike Kespohl, Ziya Kaya, et al.. (2021). Exploration of Analgesia with Tramadol in the Coxsackievirus B3 Myocarditis Mouse Model. Viruses. 13(7). 1222–1222. 3 indexed citations
7.
Luu, Maik, Meike Kespohl, Rossana Romero, et al.. (2021). Transcription factor c-Rel mediates communication between commensal bacteria and mucosal lymphocytes. Journal of Leukocyte Biology. 111(5). 1001–1007. 2 indexed citations
8.
Kespohl, Meike, Karin Klingel, Martin Voß, et al.. (2020). Protein modification with ISG15 blocks coxsackievirus pathology by antiviral and metabolic reprogramming. Science Advances. 6(11). eaay1109–eaay1109. 31 indexed citations
9.
10.
Fischer, Andrea, Carl Christoph Goetzke, Martina Sauter, et al.. (2020). Heart-Specific Immune Responses in an Animal Model of Autoimmune-Related Myocarditis Mitigated by an Immunoproteasome Inhibitor and Genetic Ablation. Circulation. 141(23). 1885–1902. 64 indexed citations
11.
Goetzke, Carl Christoph, Meike Kespohl, Martina Sauter, et al.. (2018). Silencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis. Frontiers in Immunology. 9. 2303–2303. 29 indexed citations
12.
Beling, Antje & Meike Kespohl. (2018). Proteasomal Protein Degradation: Adaptation of Cellular Proteolysis With Impact on Virus—and Cytokine-Mediated Damage of Heart Tissue During Myocarditis. Frontiers in Immunology. 9. 2620–2620. 12 indexed citations
13.
Althof, Nadine, Carl Christoph Goetzke, Meike Kespohl, et al.. (2018). The immunoproteasome‐specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis. EMBO Molecular Medicine. 10(2). 200–218. 53 indexed citations
14.
Goetzke, Carl Christoph, Meike Kespohl, Martina Sauter, et al.. (2018). Silencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis. MDC Repository (Max-Delbrueck-Center for Molecular Medicine). 1 indexed citations
15.
Kespohl, Meike, Niyati Vachharajani, Maik Luu, et al.. (2017). The Microbial Metabolite Butyrate Induces Expression of Th1-Associated Factors in CD4+ T Cells. Frontiers in Immunology. 8. 1036–1036. 227 indexed citations
16.
Klingel, Karin, Martin Voß, Meike Kespohl, et al.. (2015). The immunoproteasome controls the availability of the cardioprotective pattern recognition molecule Pentraxin3. European Journal of Immunology. 46(3). 619–633. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tai‐Ju Hwang Breakdown of academic impact, for papers by Daniel Peltier Breakdown of academic impact, for papers by Sadia Ahmad Breakdown of academic impact, for papers by Honglin Xu Breakdown of academic impact, for papers by Andrew D. Hildreth Breakdown of academic impact, for papers by Amanda Fisher Breakdown of academic impact, for papers by Zaneta Sibinska Breakdown of academic impact, for papers by Fabian Linden Breakdown of academic impact, for papers by Elisabeth Errazuriz-Cerda
Rankless by CCL
2026